< Back to previous page

Publication

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia

Journal Contribution - Journal Article

Recent studies of acute lymphoblastic leukemia have identified activating mutations in components of the interleukin-7 receptor complex (IL7R, JAK1, and JAK3). It will be of interest to investigate both JAK1 and JAK3 kinase inhibitors as targeted agents for these leukemias.
Journal: Journal of Hematology & Oncology
ISSN: 1756-8722
Issue: 1
Volume: 8
Pages: 91
Publication year:2015
BOF-keylabel:yes
IOF-keylabel:yes
BOF-publication weight:6
CSS-citation score:1
Authors from:Government, Higher Education
Accessibility:Open